Viewing Study NCT05182957


Ignite Creation Date: 2025-12-24 @ 6:47 PM
Ignite Modification Date: 2026-01-25 @ 11:29 AM
Study NCT ID: NCT05182957
Status: UNKNOWN
Last Update Posted: 2023-01-31
First Post: 2021-12-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Study on Anti-PD-1 Plus Lenalidomide and Azacitidine in Relapsed/Refractory Peripheral T-cell Lymphoma
Sponsor: The First Affiliated Hospital of Soochow University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsed/Refractory Peripheral T-cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Anti-PD-1 monoclonal antibody,Lenalidomide,Azacitidine View